Long‐Term Safety Profile of Ruxolitinib in Chronic Myeloproliferative Neoplasms: A Comprehensive Real‐World AnalysisAlberto Blanco Sánchez, Joaquín Martínez‐López, Gonzalo Carreño‐Tarragona et al.|eJHaem|2025Cited by 3